DARE-trial: A trial studying the effect of the SeQuent Please drug-eluting balloon compared to the Xience Prime drug-eluting stent for the treatment of stenosis of an earlier implanted stent.
- Conditions
- In-stent restenosisMinimal lumen diameterIn-stent restenoseMinimale lumen diameter
- Registration Number
- NL-OMON29409
- Lead Sponsor
- Academic Medical Center-University of Amsterdam, department of cardiology
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 270
Inclusion Criteria
1. Restenosis of the initially stented main vessel, including ostial, left main and bifurcation lesions as well as venous or arterial grafts;
2. Restenosis of any type of stent; all drug-eluting stents or bare metal stents;
Exclusion Criteria
1. The impossibility to arrange a follow-up coronary angiography at 6 months (± 1 month) after baseline procedure is considered an exclusion criterion for this study;
2. Patients have to meet the inclusion criteria;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method